Acadian Asset Management
WHWK

Acadian Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

Acadian Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Buy
70,101
+45,467
+185% +$142K ﹤0.01% 1539
2025
Q4 		$58K Sell
24,634
-1,572
-6% -$3.61K ﹤0.01% 1768
2025
Q3 		$49K Buy
+26,206
New +$48.2K ﹤0.01% 1648
2021
Q4 		– Sell
-20,343
Closed -$597K – 1882
2021
Q3 		$597K Sell
20,343
-84,493
-81% -$2.58M ﹤0.01% 996
2021
Q2 		$2.66M Sell
104,836
-22,596
-18% -$516K 0.01% 631
2021
Q1 		$2.47M Buy
127,432
+26,798
+27% +$617K 0.01% 677
2020
Q4 		$1.48M Buy
100,634
+21,912
+28% +$469K 0.01% 859
2020
Q3 		$1.77M Buy
+78,722
New +$1.66M 0.01% 703
2019
Q4 		– Sell
-12,437
Closed -$127K – 2094
2019
Q3 		$127K Hold
12,437
– – ﹤0.01% 1431
2019
Q2 		$170K Buy
12,437
+2,342
+23% +$35.5K ﹤0.01% 1265
2019
Q1 		$137K Buy
10,095
+9,000
+822% +$387K ﹤0.01% 1445
2018
Q4 		$28K Buy
+1,095
New +$34.9K ﹤0.01% 1518

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Acadian Asset Management's WHWK Position: Q1 2026 in Review

Acadian Asset Management increased its Whitehawk Therapeutics (WHWK) stake by 185% in Q1 2026, buying an estimated $142K and bringing the position to 70,101 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #1539.

Acadian Asset Management first reported a position in WHWK in Q4 2018 and has held it in 12 quarters since. The position peaked at $2.66M in Q2 2021. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Acadian Asset Management held 70,101 shares of Whitehawk Therapeutics worth $239K as of Q1 2026.
  • Acadian Asset Management bought 45,467 Whitehawk Therapeutics shares in Q1 2026, an estimated $142K.
  • Whitehawk Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1539 holding.
  • Acadian Asset Management first reported a position in Whitehawk Therapeutics in Q4 2018 and has held it in 12 quarters since.
  • Acadian Asset Management's Whitehawk Therapeutics position peaked at $2.66M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.